<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.potomachealthnews.com/article/904567540-als-united-applauds-introduction-of-act-for-als-reauthorization-legislation</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T21:29:48+00:00</news:publication_date>
        <news:title>ALS United Applauds Introduction of ACT for ALS Reauthorization Legislation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24643683-als-united-logo-561x261.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904572410-zydoc-to-exhibit-at-ascrs-2026-and-introduce-no-cost-clinical-documentation-with-7-day-human-edited-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T21:01:52+00:00</news:publication_date>
        <news:title>ZyDoc to Exhibit at ASCRS 2026 and Introduce No-Cost Clinical Documentation with 7-Day Human-Edited Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24812155-61-percent-faster-capture-more-1200x628.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904534515-top-business-school-graduate-students-to-compete-in-annual-healthcare-case-competition-this-week-in-washington-d-c</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T16:46:44+00:00</news:publication_date>
        <news:title>Top Business School Graduate Students to Compete in Annual Healthcare Case Competition This Week in Washington, D.C.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24828685-heal-network-logo-719x250.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904508543-community-oncology-alliance-submits-pbm-regulation-recommendations-to-department-of-labor</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T13:22:36+00:00</news:publication_date>
        <news:title>Community Oncology Alliance Submits PBM Regulation Recommendations to Department of Labor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/698840-coa-new-seal-2019-update-1800x1800.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904337413-bliik-launches-digital-health-platform-to-improve-access-to-autism-therapy-services</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T12:49:51+00:00</news:publication_date>
        <news:title>Bliik Launches Digital Health Platform to Improve Access to Autism Therapy Services</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24827763-bliik-logo-1920x574.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904313254-us-navy-veterans-mesothelioma-lung-cancer-advocate-urges-a-navy-ship-submarine-veteran-who-had-shipyard-duty-and-now-has-mesothelioma-or-lung-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T09:45:00+00:00</news:publication_date>
        <news:title>US Navy Veterans Mesothelioma &amp; Lung Cancer Advocate Urges a Navy Ship-Submarine Veteran Who Had Shipyard Duty and Now Has Mesothelioma or Lung Cancer to Call for Direct Access to the USA&#39;s Top Lawyers for Compensation </news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/19400638-us-navy-flag-251x201.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904581911-found-health-claims-evaluated-affordable-glp-1-weight-loss-medication-provider-with-free-online-insurance-check</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T21:25:19+00:00</news:publication_date>
        <news:title>Found Health Claims Evaluated: Affordable GLP-1 Weight Loss Medication Provider with Free Online Insurance Check</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Found-Health.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904581705-aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T21:00:00+00:00</news:publication_date>
        <news:title>Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f41706a5-9f61-4772-83f1-6aa50c660788/small/enable-injections-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904581691-fda-removes-partial-clinical-hold-on-macrogenics-linnet-study</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:30:00+00:00</news:publication_date>
        <news:title>FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904568361-polyrizon-ltd-announces-closing-of-3-5-million-registered-direct-and-private-placements</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:16:00+00:00</news:publication_date>
        <news:title>Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MTZmNTJlZmItOTljMi00Y2I1LThjMTMtMGYwOTZiN2UxN2JiLTUwMDEyOTIyMy0yMDI2LTA0LTA4LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904568472-universal-door-meditation-center-hosts-free-public-celebration-of-awakened-zen-master-thich-dieu-thien-s-25-year-milestone-april-11-in-sugar-land</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:15:20+00:00</news:publication_date>
        <news:title>Universal Door Meditation Center Hosts Free Public Celebration of Awakened Zen Master Thich Dieu Thien&#39;s 25-Year Milestone April 11 in Sugar Land, Texas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/afd79128-3253-46ac-9253-71e6bac13f23/small/udmc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904568203-avita-medical-secures-10-year-barda-agreement-worth-up-to-25-5m-to-bolster-u-s-burn-emergency-preparedness</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:10:00+00:00</news:publication_date>
        <news:title>AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567716-immucell-announces-a-28-4-increase-in-product-sales-in-q1-of-2026-based-on-preliminary-unaudited-sales-results</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567720-outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567722-option-care-health-to-announce-first-quarter-2026-financial-results-and-host-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OWFhZTIwODktMDI1Ni00ZDcyLWEwMGItMGZmYzc2MWFiZmM0LTEwMTk5NzQtMjAyNi0wNC0wOC1lbg==/tiny/Option-Care-Health-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567728-crinetics-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ff5e7cfa-b9fb-4679-8bf3-6e9d25207b83/small/crinetics-logo-trademark-jpg-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567783-clover-health-to-report-first-quarter-2026-financial-results-on-may-6-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a48a25b-b654-4d62-adb3-d1a776346264/small/clover-logo-green-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567977-rxsight-highlights-300-000-light-adjustable-lens-implant-milestone-and-strong-scientific-presence-at-ascrs-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904568342-annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904568377-kyntra-bio-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904568428-nexgel-reschedules-shareholder-update-conference-call-to-april-15th-at-4-30-p-m-et-to-provide-update-on-celularity-transaction</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567669-inventiva-annonce-le-d-p-t-de-son-document-d-enregistrement-universel-2025-et-de-son-rapport-annuel-2025-form-20-f</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:00:00+00:00</news:publication_date>
        <news:title>Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2025 et de son Rapport Annuel 2025 (« Form 20-F ») </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567678-proqr-highlights-pipeline-expansion-and-multiple-upcoming-clinical-catalysts-at-investor-and-analyst-event</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:00:00+00:00</news:publication_date>
        <news:title>ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904567684-inventiva-announces-filing-of-its-2025-universal-registration-document-and-2025-annual-report-on-form-20-f</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:00:00+00:00</news:publication_date>
        <news:title>Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/logo-iva-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904554654-parker-university-women-s-volleyball-wins-2026-ncvf-national-championship</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T18:44:29+00:00</news:publication_date>
        <news:title>PARKER UNIVERSITY WOMEN’S VOLLEYBALL WINS 2026 NCVF NATIONAL CHAMPIONSHIP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NjBkOWNmMWMtMWQ4NS00NmY4LWFjNDYtODBmZjAzMDhhNTc5LTEyMTMzODItMjAyNi0wNC0wOC1lbg==/tiny/Parker-University.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904554686-neura-supplement-claims-evaluated-the-7-second-red-goji-berry-recipe-memory-trick-for-neura-shield-cognitive-performance</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T18:41:48+00:00</news:publication_date>
        <news:title>Neura Supplement Claims Evaluated: The 7-Second Red Goji Berry Recipe Memory Trick for Neura Shield Cognitive Performance</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Neura-Supplement.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904542286-ergodyne-readies-work-crews-for-the-dangers-of-warmer-temps</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T17:00:00+00:00</news:publication_date>
        <news:title>Ergodyne Readies Work Crews for the Dangers of Warmer Temps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NTgwMTM4MWQtYWIwOS00ZWIwLTlmMzAtYWExM2UyNDk3NTM5LTExODg4MTAtMjAyNi0wNC0wOC1lbg==/tiny/Ergodyne.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904542370-ascendis-pharma-to-list-ordinary-shares-directly-on-nasdaq</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T16:00:00+00:00</news:publication_date>
        <news:title>Ascendis Pharma to List Ordinary Shares Directly on Nasdaq</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904529759-trogenix-announces-publication-of-breakthrough-pre-clinical-data-in-nature-demonstrating-complete-tumour-eradication-and-durable-protection-in</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T15:02:54+00:00</news:publication_date>
        <news:title>Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/1df677d2-fb59-4859-a4a8-d74bdb945eca/small/trogenix-rgb-80-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904529871-new-23andme-research-institute-study-identifies-genetic-predictors-for-glp-1-weight-loss-efficacy-and-side-effects</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T15:00:00+00:00</news:publication_date>
        <news:title>New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e614a219-c44d-4fb3-8c94-b3a330509af9/small/23andme-ri-logo-stacked-color-min-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904530092-booking-health-releases-2026-report-on-advanced-head-and-neck-cancer-treatment-for-international-patients</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T14:50:00+00:00</news:publication_date>
        <news:title>Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3226262/1775134246_1024_depositphotos_844658038_xl-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904519657-steadman-philippon-research-institute-and-hospital-for-special-surgery-to-host-vail-hip-summit-april-9-11-at-four-seasons-resort-vail</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T14:00:05+00:00</news:publication_date>
        <news:title>Steadman Philippon Research Institute and Hospital for Special Surgery to Host Vail Hip Summit April 9–11 at Four Seasons Resort Vail</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZmRlMzIwMzQtOGY1Zi00MjQ0LTljNmYtNzM3ODFmMWM5NTkxLTExMDM2NjEtMjAyNi0wNC0wOC1lbg==/tiny/Steadman-Philippon-Research-In.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904519445-root-brands-addresses-the-glp-1-gap-with-crush-and-sculpt-a-science-driven-protocol-for-metabolic-and-muscle-support-after-ozempic-and-wegovy</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T13:41:42+00:00</news:publication_date>
        <news:title>ROOT Brands® Addresses the GLP-1 Gap with CRUSH and SCULPT, a Science-Driven Protocol for Metabolic and Muscle Support After Ozempic® and Wegovy®</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NGE2MTEwYWQtOWMzMy00YWU3LWFmZDMtZjQwNDRmNmI3NzRkLTUwMDE1MDU0NC0yMDI2LTA0LTA4LWVu/tiny/The-ROOT-Brands.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904170604-new-national-report-reveals-critical-gaps-in-healthcare-transitions-calls-for-urgent-policy-reform</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T09:00:00+00:00</news:publication_date>
        <news:title>New National Report Reveals Critical Gaps in Healthcare Transitions, Calls for Urgent Policy Reform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/21186395-ntocc-logo-2917x1167.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904518691-novabridge-reports-full-year-2025-financial-results-and-provides-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:50:00+00:00</news:publication_date>
        <news:title>NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15/small/novabridge-logo-en-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364603-vtv-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:15:00+00:00</news:publication_date>
        <news:title>vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/27198d2d-fdd5-4f74-8f54-7a9e5876e06d/small/vtv-therapeutics-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364649-voting-rights-and-shares-capital-of-the-company</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:15:00+00:00</news:publication_date>
        <news:title>Voting Rights and Shares Capital of the Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364730-information-mensuelle-relative-au-nombre-total-de-droits-de-vote-et-d-actions-composant-le-capital-social</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:15:00+00:00</news:publication_date>
        <news:title>Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364771-avita-medical-showcases-acute-burn-and-wound-care-portfolio-at-aba-2026-featuring-new-cohealyx-data</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:10:00+00:00</news:publication_date>
        <news:title>AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364829-as-easter-travel-triggers-bed-bug-infestation-warning-fantastic-pest-control-rolls-out-faster-more-efficient-low-pesticide-heat-treatment</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:06:00+00:00</news:publication_date>
        <news:title>As Easter Travel Triggers Bed Bug Infestation Warning Fantastic Pest Control Rolls Out Faster, More Efficient, Low-pesticide Heat Treatment</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3226340/65c749bddbdcebd94903357da3d456ca_44_file.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364502-brightspring-health-services-inc-to-announce-first-quarter-2026-financial-results-on-may-1-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:05:00+00:00</news:publication_date>
        <news:title>BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/db25f94c-83a2-46ba-8d53-c9a0768a71bd/small/brightspring-healthservices-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364525-vaxcyte-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:05:00+00:00</news:publication_date>
        <news:title>Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364745-iridex-announces-new-partnership-with-eyeprogpo-to-expand-member-access-to-retina-laser-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:05:00+00:00</news:publication_date>
        <news:title>Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2bb80159-a920-428b-aa69-c2f32e3038c9/small/iridex-corporate-logo-horizontal-rgb-m02-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364770-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:05:00+00:00</news:publication_date>
        <news:title>Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904364836-amneal-to-report-first-quarter-2026-results-on-may-1-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:01:00+00:00</news:publication_date>
        <news:title>Amneal to Report First Quarter 2026 Results on May 1, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904354949-lemaitre-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T18:39:10+00:00</news:publication_date>
        <news:title>LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904345601-mhm-invests-237-5-million-to-create-a-healthier-future-across-south-texas</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:47:05+00:00</news:publication_date>
        <news:title>MHM Invests $237.5 Million to Create a Healthier Future Across South Texas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MjM4YmQ3ZDgtN2QzYy00MjdjLTk2ODQtNDllZjc1MjY2N2FiLTEyOTc4OTgtMjAyNi0wNC0wNy1lbg==/tiny/Methodist-Healthcare-Ministrie.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904345599-global-dna-read-write-and-edit-market-to-surge-to-67-7-billion-by-2030-driven-by-crispr-advances-genomic-diagnostics-and-expanding-clinical</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:44:41+00:00</news:publication_date>
        <news:title>Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904345591-gluco-zen-drops-under-investigation-safety-concerns-arise-amid-researching-the-ingredients-side-effects-risk-for-glucozen</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:35:22+00:00</news:publication_date>
        <news:title>Gluco Zen Drops Under Investigation: Safety Concerns Arise Amid Researching the Ingredients&#39; Side Effects Risk for GlucoZen</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Gluco-Zen-Drops.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904345226-genfit-announces-publication-of-the-2025-universal-registration-document</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:30:00+00:00</news:publication_date>
        <news:title>GENFIT Announces Publication of the 2025 Universal Registration Document   </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/YjA0MjRlZDQtMzQxZS00MDdhLTg3ZGEtZmVhOTQ4ZDQzZWI3LTEwMTEyNjgtMjAyNi0wNC0wNy1lbg==/tiny/GENFIT-S-A-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904345280-genfit-mise-disposition-du-document-d-enregistrement-universel-2025</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:30:00+00:00</news:publication_date>
        <news:title>GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025   </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/YjA0MjRlZDQtMzQxZS00MDdhLTg3ZGEtZmVhOTQ4ZDQzZWI3LTEwMTEyNjgtMjAyNi0wNC0wNy1mcg==/tiny/GENFIT-S-A-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904345559-natural-remedies-awarded-american-botanical-council-s-2026-varro-e-tyler-commercial-investment-in-phytomedicinal-research-award</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:19:41+00:00</news:publication_date>
        <news:title>Natural Remedies Awarded American Botanical Council’s 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/afb640f0-73d1-4cd2-bcbe-9a80b381d7cc/medium/2026-abc-varro-e-tyler-commercial-investment-in-phytomedicin.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904336536-coeptis-announces-approval-of-z-squared-inc-s-nasdaq-listing-application</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T16:05:56+00:00</news:publication_date>
        <news:title>Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6ef667b8-3767-4031-9180-f4ba33c81938/small/coeptis-logo-final-rgb-300dpi-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904327021-heartfocus-and-inteleos-launch-first-ai-cardiac-pocus-certification</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T15:24:18+00:00</news:publication_date>
        <news:title>HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NTFkODg1MzItY2Q4MC00MTY2LTk4NjItODc1OTc1OTA4YjUyLTEyNDUwMzItMjAyNi0wNC0wNy1lbg==/tiny/Inteleos-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904326952-3-ways-pharmacists-can-help-maximize-your-glp-1-experience</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T15:01:15+00:00</news:publication_date>
        <news:title>3 Ways Pharmacists Can Help Maximize Your GLP-1 Experience</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/f72143cc-6829-468e-aeb9-94a8dbdcb874/17866-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904318679-speke-ai-to-showcase-ambient-ai-solutions-at-uca-s-2026-urgent-care-convention</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:37:17+00:00</news:publication_date>
        <news:title>Speke AI to Showcase Ambient AI Solutions at UCA’s 2026 Urgent Care Convention</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NTE3ZDRhZjgtMjgwNi00MGNkLThlOGItYmQwNzU4OTBiMDNkLTUwMDE1NDA4MS0yMDI2LTA0LTA3LWVu/tiny/Speke-AI.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904318654-nextel-medical-corp-announces-pivotal-milestone-in-commercial-launch-of-patent-protected-nanog-dna-cancer-screening-test</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:30:00+00:00</news:publication_date>
        <news:title>NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZmQ2OTkwNDMtN2QzOS00OWQ1LThhYzctYzg5MzFjMjgwODMwLTUwMDE1ODM1Mi0yMDI2LTA0LTA3LWVu/tiny/Exousia-Pro-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904318466-bioora-and-octane-biotech-sign-letter-of-intent-to-expand-cell-therapy-manufacturing-using-the-cocoon-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:15:00+00:00</news:publication_date>
        <news:title>BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YzFhYmQ1NzYtNzA3My00Y2JiLWE2MGQtMjM3ZDBmYzMxNTJhLTEzMDQwMTAtMjAyNi0wNC0wNy1lbg==/tiny/Octane-Medical-Group.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904318295-regional-health-properties-reports-fourth-quarter-2025-results</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:05:00+00:00</news:publication_date>
        <news:title>Regional Health Properties Reports Fourth Quarter 2025 Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bfd51062-4a60-4cf0-9f2f-a4b109b52e4a/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904318008-folia-health-launches-app-based-study-to-unlock-novel-real-world-evidence-of-symptom-burden-and-unmet-need-for-patients-and-caregivers-in-cidp</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:00:00+00:00</news:publication_date>
        <news:title>Folia Health Launches App-Based Study to Unlock Novel Real-World Evidence of Symptom Burden and Unmet Need for Patients and Caregivers in CIDP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/858e11f4-96a0-4321-93eb-d278df849ccf/small/untitled-design-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904318126-inc-recognizes-u-s-oral-surgery-management-for-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:41:00+00:00</news:publication_date>
        <news:title>Inc. Recognizes U.S. Oral Surgery Management for Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9472c27c-8b6d-4c87-95fd-31f1f0140263/small/usosm-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904310228-merakris-therapeutics-provides-fda-update-and-reports-interim-findings-for-mtx-001-in-venous-leg-ulcers</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:30:00+00:00</news:publication_date>
        <news:title>Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5b9c5fed-3332-4d4d-b8b6-6ab1b15faaed/small/mrks-brand-logo-final-fullcolor-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904310391-nurexone-biologic-s-u-s-subsidiary-exo-top-and-florida-based-bioxtek-sign-strategic-loi-for-exosome-manufacturing-and-commercialization</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:18:00+00:00</news:publication_date>
        <news:title>NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1514c671-cc84-4bcb-82d7-b834fce40882/small/nurexone-logo-rebrand-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904308717-cellution-biologics-inc-announces-official-entry-into-the-ocular-market-at-ascrs-with-the-launch-of-opticover</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:11:00+00:00</news:publication_date>
        <news:title>Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/10957e60-6696-483a-9df0-88f8713da811/medium/opticover.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904309254-srx-health-solutions-returns-5-69-in-march-2026-driven-by-emjx-artificial-intelligence-ai-engine</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:05:00+00:00</news:publication_date>
        <news:title>SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904310171-medx-holdings-reports-strong-q4-results-achieves-net-profitability-and-announces-strategic-partnerships-to-supercharge-franchise-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:05:00+00:00</news:publication_date>
        <news:title>MEDX HOLDINGS REPORTS STRONG Q4 RESULTS, ACHIEVES NET PROFITABILITY, AND ANNOUNCES STRATEGIC PARTNERSHIPS TO SUPERCHARGE FRANCHISE EXPANSION</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/995733cb-620f-4ea6-b204-8b5b5689df30/small/medx-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904310583-treace-announces-first-surgical-cases-with-the-superbite-compression-screw-system</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:04:29+00:00</news:publication_date>
        <news:title>Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6f3a2631-2457-4100-950a-3dec602ec68d/medium/superbite-compression-screw-system.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904308778-saladax-biomedical-to-expand-international-access-to-drug-level-testing-for-psychiatry-and-oncology</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/M2NiMWYwYzAtNjA1My00OWFiLWFkN2ItZjY5YzgxNjE4MzI3LTUwMDEyNDYwOC0yMDI2LTA0LTA3LWVu/tiny/Saladax-Biomedical-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904308956-pathai-and-medstar-health-announce-partnership-to-deploy-the-aisight-dx-digital-pathology-platform-and-advanced-ai-applications</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ab2bfc12-ae80-47c6-9345-a98783489ed7/small/pathai-logo-standard-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904309046-death-by-a-thousand-vendors-81-of-employers-are-hiring-just-to-keep-up-with-digital-health-vendor-sprawl</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Death by a Thousand Vendors: 81% of Employers Are Hiring Just to Keep Up with Digital Health Vendor Sprawl</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b8d88974-2aeb-4baa-ad3b-2ab758ed4dd9/small/solera-main-logo-red-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904309197-lumin-health-appoints-matthew-mosquera-md-ms-as-regional-medical-director-and-site-director-of-lumin-cambridge</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb31fc23-dea3-476e-971b-6265973b0739/medium/matthew-mosquera.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904310148-ai-and-online-health-information-are-booming-but-americans-don-t-fully-trust-what-they-find</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>AI and Online Health Information Are Booming, But Americans Don’t Fully Trust What They Find</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NjE3YzhiYjItN2E5Yy00MjE5LWI1YTQtMGUzMmVlZjY3NzM2LTUwMDE2MDA3Mi0yMDI2LTA0LTA3LWVu/tiny/American-Association-of-Nurse-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904309350-outlook-therapeutics-announces-formal-dispute-resolution-request-for-ons-5010-lytenava-bevacizumab-vikg-accepted-by-fda</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:50:00+00:00</news:publication_date>
        <news:title>Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904309225-vivos-therapeutics-completes-private-placement-with-existing-private-equity-investor-new-seneca-partners</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:45:00+00:00</news:publication_date>
        <news:title>Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/22d07f60-2e17-421d-bbc3-748c2402061e/small/picture2-jpg.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904308798-moleculin-releases-next-ceo-corner-segment-highlighting-annamycin-s-non-cardiotoxic-profile</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:36:00+00:00</news:publication_date>
        <news:title>Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299971-20-20-biolabs-selected-by-evexia-diagnostics-to-offer-onetest-for-cancer-through-evexia-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date>
        <news:title>20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299756-xenon-to-highlight-phase-3-x-tole2-long-term-data-for-azetukalner-in-focal-onset-seizures-at-2026-aan-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Xenon to Highlight Phase 3 X-TOLE2 &amp; Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299796-abeona-therapeutics-announces-appointment-of-keith-a-goldan-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299918-clover-health-empowers-members-to-take-charge-of-their-health-data-through-healthex-partnership</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a48a25b-b654-4d62-adb3-d1a776346264/small/clover-logo-green-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299951-integra-lifesciences-unveils-new-real-world-evidence-highlighting-primatrix-utilization</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/00cf1e29-7492-4f89-bab1-6691cf2253c4/medium/primatrix-dermal-scaffold.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299992-ss-innovations-to-host-smrsc-2026-in-new-delhi-india-from-april-9-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cef267e0-040f-4889-a706-cc4d0ae49e55/small/new-logo-april-23-2025-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300074-cormedix-to-participate-in-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>CorMedix to Participate in Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300165-milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300233-cdt-notes-sarborg-publication-of-prism-framework-expanding-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>CDT Notes Sarborg Publication of PRISM Framework Expanding AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MjNiMmZlYjctZjk3NS00MWViLThkMjktZWUwZGQ1YzVkNzRjLTEyNzQxMDItMjAyNi0wNC0wNy1lbg==/tiny/CDT-Equity-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299831-biorestorative-therapies-announces-strategic-collaboration-with-203-creates-to-build-and-commercialize-biocosmeceutical-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:15:00+00:00</news:publication_date>
        <news:title>BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299713-nextcure-receives-fast-track-designation-for-sim0505-cdh6-adc-in-ovarian-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:05:00+00:00</news:publication_date>
        <news:title>NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300472-emergent-biosolutions-launches-new-narcan-nasal-spray-carrying-case-and-multipacks-alongside-college-campus-outreach-to-expand-opioid-overdose</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:05:00+00:00</news:publication_date>
        <news:title>Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3fcbfc65-93d7-475f-9f23-b47fbf2ab8ca/medium/narcan-nasal-spray-multipacks.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299511-evaxion-announces-last-patient-visit-in-one-year-extension-of-phase-2-trial-with-personalized-cancer-vaccine-evx-01</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299601-lyell-immunopharma-announces-participation-in-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299705-inhibikase-therapeutics-announces-enrollment-of-first-patient-in-improve-pah-global-phase-3-study-of-ikt-001-in-the-treatment-of-pulmonary-arterial</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/32b8d8bc-ebf8-43c0-866a-6613b22263b1/small/ikt-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299752-amneal-announces-2-million-donation-to-support-patient-access-to-essential-medicines-during-parkinson-s-awareness-month</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299830-crispr-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299833-gatc-health-and-uc-irvine-announce-landmark-pnas-publication-validating-ai-platform-for-opioid-use-disorder-treatment</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>GATC Health and UC Irvine Announce Landmark PNAS Publication Validating AI-Platform for Opioid Use Disorder Treatment</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8252f5cc-6aca-4b39-b708-845c0ce98b86/small/color-logo-vector-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299835-solid-biosciences-to-participate-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Solid Biosciences to Participate at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299849-valitor-announces-oral-presentation-at-the-upcoming-association-for-research-in-vision-and-ophthalmology-arvo-2026-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299853-route-92-medical-announces-50-million-growth-financing</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Route 92 Medical Announces $50 Million Growth Financing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/526036da-ddbe-4a9a-9222-9570f7cd6544/small/r-rt92-logo-rbg0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299871-akebia-therapeutics-to-conduct-investor-meetings-at-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299961-aclarion-highlights-growing-adoption-of-nociscan-at-the-london-clinic-with-new-physician-video</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300025-calidi-biotherapeutics-announces-speaker-presentation-at-asgct-conference-in-boston-on-may-14-2026-highlighting-the-redtail-platform-s-ability-to</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300073-corbus-pharmaceuticals-announces-broad-alignment-with-fda-on-registration-path-for-crb-701-in-second-line-hnscc-and-cervical-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300089-liquidia-corporation-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Liquidia Corporation to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300151-electrocore-announces-first-patient-enrollment-in-investigator-led-study-of-gammacore-nvns-for-ptsd</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300354-jupiter-neurosciences-appoints-kristopher-fishman-and-sanjiv-lal-to-nugevia-advisory-board</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300403-polyrizon-ltd-announces-3-5-million-registered-direct-offering-and-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/N2M3NTE1MmItYWFmMi00MDNlLWE4MTItMWIxMDg4MWYwMTRlLTUwMDEyOTIyMy0yMDI2LTA0LTA3LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300175-artelo-biosciences-regains-compliance-with-nasdaq-listing-requirements</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:50:00+00:00</news:publication_date>
        <news:title>Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299627-marvel-biosciences-secures-financial-and-strategic-investment-with-5-horizon-ventures</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d49e32dc-88d9-4694-a3dd-6e663548e80d/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299632-anavex-life-sciences-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299759-everbright-health-announces-ai-enabled-platform-to-unlock-access-to-advanced-mental-health-interventions</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Everbright Health Announces AI-Enabled Platform to Unlock Access to Advanced Mental Health Interventions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2ce4a623-23ed-4e51-9115-db1f2526bcfc/small/everbrighthealth-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299841-plus-therapeutics-receives-ama-pla-code-for-cnside-csf-tumor-cell-enumeration-test-advancing-reimbursement-and-u-s-commercial-adoption</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904299993-cognition-therapeutics-to-present-at-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Cognition Therapeutics to Present at Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a14fd627-7ccb-45e2-95fe-792bbfb83231/small/2020-0227-cognition-logo-for-gnw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300070-palvella-therapeutics-appoints-accomplished-commercial-leader-kent-taylor-as-senior-vice-president-of-sales</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300109-cervomed-to-provide-neflamapimod-clinical-program-update-and-participate-in-a-panel-on-biomarkers-at-2026-lewy-body-dementia-association-annual</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/332fd58e-5e2b-4c96-8eaf-719ac2e34f52/small/cervomed-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300157-nervgen-pharma-announces-successful-end-of-phase-2-meeting-and-fda-alignment-on-restore-a-phase-3-registrational-study-of-nvg-291-for-chronic</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904300328-weight-watchers-appoints-lisa-gavales-and-sue-gove-to-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290412-pluristyx-extends-patent-portfolio-in-universal-cell-therapy-with-new-u-s-patent-for-iact-stealth-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:09:00+00:00</news:publication_date>
        <news:title>Pluristyx Extends Patent Portfolio in Universal Cell Therapy with New U.S. Patent for iACT Stealth™ Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/22e38345-b052-4cc3-a4c3-556e798109f3/small/pluristyx-logo-blue-apr22-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290254-fennec-pharmaceuticals-announces-investigator-sponsored-study-to-be-conducted-by-university-of-arizona-cancer-center</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:03:00+00:00</news:publication_date>
        <news:title>Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290176-invivyd-launches-antibodies-for-any-body-in-partnership-with-world-champion-skier-lindsey-vonn-to-inspire-actions-that-help-support-immune-health</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:01:00+00:00</news:publication_date>
        <news:title>Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290028-ac-immune-announces-amendment-to-morphomer-tau-license-and-collaboration-agreement-with-lilly</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290055-mediwound-to-present-new-escharex-data-at-leading-wound-care-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>MediWound to Present New EscharEx® Data at Leading Wound Care Conferences </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290057-radiopharm-theranostics-and-siemens-healthineers-sign-clinical-supply-agreement-for-rad101-in-the-u-s</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/8e246920-183e-46a4-b13c-a3c9ec50ada9/small/radx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290245-sionna-therapeutics-to-participate-in-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290255-soleo-health-relocates-denver-specialty-pharmacy-to-support-continued-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Soleo Health Relocates Denver Specialty Pharmacy to Support Continued Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b3c4bcdc-fa25-4f50-8b81-09f13e80a008/small/soleo-logo-1024-x-1024-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290282-breckenridge-distillery-introduces-honey-whiskey-crafted-with-rare-nigerian-goldswarm-honey-a-must-try-for-whiskey-enthusiasts</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb623008-0c9a-49db-ab38-6e3062dd8bdb/medium/breckenridge-distillery-honey-whiskey.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290354-climb-bio-announces-fda-fast-track-designation-for-budoprutug-for-the-treatment-of-primary-membranous-nephropathy</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290361-skye-bioscience-presenting-at-glp-1-based-therapeutics-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290381-nurix-therapeutics-to-participate-in-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Nurix Therapeutics to Participate in Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290410-fortrea-unveils-fortrea-intelligent-technology-to-help-sponsors-and-sites-run-smarter-more-integrated-trials</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9fbbe00b-8782-464e-83e6-5843c563884a/small/fortrea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290597-neuronetics-comments-on-letter-from-pointillist-family-office</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Neuronetics Comments on Letter from Pointillist Family Office</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290600-okyo-pharma-announces-scientific-advisory-board-meeting-and-urcosimod-data-presentation-during-ascrs-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/23e4046d-dcf9-4dd1-945e-461e98a27d15/small/full-logo-okyo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290602-vantage-hemp-co-engages-acos-and-gpos-to-advance-participation-in-cms-cbd-pilot-program</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d38e4562-945b-4df7-8869-623c43be10f1/medium/inside-vantages-manufacturing-facility.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290206-ani-pharmaceuticals-announces-publication-of-new-day-clinical-trial-results-in-ophthalmology</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:50:00+00:00</news:publication_date>
        <news:title>ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904290397-bluejay-diagnostics-inc-announces-completion-of-624-patient-enrollments-in-symon-ii-pivotal-clinical-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:30:00+00:00</news:publication_date>
        <news:title>Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0d4a766-5115-448d-ba8a-d522100949f1/small/bjdx-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904280802-serina-therapeutics-to-present-at-the-5th-lnp-formulation-process-development-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>Serina Therapeutics to Present at the 5th LNP Formulation &amp; Process Development Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7f8e4304-8465-4d4d-a7e3-ebc4eae51f29/small/yellow-burts-blue-text-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904280810-ascellahealth-named-to-financial-times-americas-fastest-growing-companies-2026-list</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5278c55f-330c-41a1-8446-d8b1a07bbc55/small/ah-logo-colornotag-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904280821-greenwich-lifesciences-provides-update-on-patent-claims-potentially-doubling-gp2-market-potential</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904263002-oculis-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T08:00:00+00:00</news:publication_date>
        <news:title>Oculis to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904253341-sononeu-exits-stealth-as-key-part-of-us-government-funded-research-program-worth-up-to-41-3m-to-advance-sonogenetics-into-clinic</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T07:00:00+00:00</news:publication_date>
        <news:title>SonoNeu exits stealth as key part of US Government-funded research program worth up to $41.3m to advance sonogenetics into clinic</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/28b90f6b-ca31-4be4-92ca-1d1e341f55f3/small/sononeu-small-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904235360-press-release-sanofi-s-lunsekimig-met-primary-and-key-secondary-endpoints-in-phase-2-respiratory-studies-in-asthma-and-crswnp</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T05:00:00+00:00</news:publication_date>
        <news:title>Press Release:  Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904235375-communiqu-de-presse-le-lunsekimig-de-sanofi-a-atteint-les-crit-res-d-valuation-principal-et-secondaires-cl-s-dans-les-tudes-respiratoires-de-phase</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T05:00:00+00:00</news:publication_date>
        <news:title>Communiqué de presse: Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904203057-memogenesis-claims-evaluated-researching-the-latest-memo-genesis-formulation-facts</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T01:10:16+00:00</news:publication_date>
        <news:title>MemoGenesis Claims Evaluated: Researching the Latest Memo Genesis Formulation Facts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/MemoGenesis.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904203030-ryoncil-continues-successful-first-year-launch-with-net-sales-of-us-30-3m-in-march-quarter</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T01:03:58+00:00</news:publication_date>
        <news:title>Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904187967-q1-2026-strong-revenue-growth-and-therapeutics-pipeline-advancement</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T23:37:15+00:00</news:publication_date>
        <news:title>Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.potomachealthnews.com/article/904187944-organogenesis-achieves-primary-endpoint-in-randomized-controlled-trial-of-puraply-am</loc>
      <news:news>
        <news:publication>
          <news:name>Potomac Health News</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T23:02:29+00:00</news:publication_date>
        <news:title>Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
